Results 51 to 60 of about 2,823 (143)
Journal of Fungi, 2021 Invasive candidiasis is known to be one of the most common healthcare-associated complications and is caused by several Candida species. First-line drugs, particularly echinocandins, are effective, but there are increasing reports of resistance to these ...
Laura Trovato +8 more
doaj +1 more source
Food Frontiers, Volume 7, Issue 4, July 2026.Antifungal effects and underlying mechanism of the action of the supercritical fluid extracted from the cumin (Cuminum cyminum) seeds and its volatile phyto‐constituents against pathogenic Aspergillus fumigatus. ABSTRACT Spices are aromatic culinary ingredients used worldwide for enhancing food flavors, folklore therapy, and their antiseptic ...
Acharya Balkrishna +7 more
wiley +1 more source
Microbial Biotechnology, Volume 19, Issue 7, July 2026.Systematic functional characterization of all eight GATA‐type transcription factors in the nematode‐trapping fungus Arthrobotrys flagrans reveals a novel, light‐independent WC1/WC2–Sre1 transcriptional cascade that orchestrates both trap formation and chlamydospore development, providing actionable targets for engineering superior biocontrol strains ...
Yu Zhang +6 more
wiley +1 more source
Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait
Journal of Fungi, 2020 The emerging, often multidrug-resistant Candida auris is increasingly being associated with outbreaks in healthcare facilities. Here we describe the molecular epidemiology of a C.
Wadha Alfouzan +11 more
doaj +1 more source
Mycoses, Volume 69, Issue 5, May 2026.ABSTRACT Background The incidence of Candida tropicalis isolation is increasing in hospital settings. High azole resistance and mortality rates make it a pathogen that requires further analysis. Methods Fourteen azole resistant Candida glabrata clinical isolates were collected from a Lebanese hospital and analysed through whole genome sequencing for ...
Christy Chedraoui +9 more
wiley +1 more source
Emerging Microbes and Infections, 2023 Candida parapsilosis is becoming a predominant non-albicans cause of invasive candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis. Resistance to echinocandins in C.
Yating Ning +18 more
doaj +1 more source
The Epidemiology and Infection Control of Candida Auris in Shanghai
Mycoses, Volume 69, Issue 4, April 2026.ABSTRACT Background Candida auris is a globally emerging multidrug‐resistant fungus. Its dissemination is driven by patient movement and asymptomatic carriers. However, molecular epidemiological studies linking imported cases to local strains in large metropolitan areas remain limited.
Mingjing Wei +8 more
wiley +1 more source
Successful Management of Candida auris Bloodstream Infection in an Elderly Patient: A Case Report
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT Candida auris is an emerging multidrug‐resistant pathogen frequently misidentified by conventional methods, posing diagnostic and infection‐control challenges, particularly in low‐ and middle‐income countries. We report a 74‐year‐old male in Dhaka, Bangladesh, with multiple comorbidities who developed Candidemia.
Arif Hasan Chowdhury +8 more
wiley +1 more source
Two echinocandin-resistant Candida glabrata FKS mutants from South Africa
Medical Mycology Case Reports, 2016 Echinocandins are recommended as first-line agents to treat invasive infections caused by Candida glabrata since this organism is inherently less susceptible to azoles. However, resistance to echinocandins has been described in C.
Serisha D. Naicker +6 more
doaj +1 more source
Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans [PDF]
, 2015 A rapid molecular-based assay for the detection of the Candida albicans FKS1 gene mutations responsible for resistance to echinocandin drugs was designed and evaluated.
Dudiuk, Catiana Beatriz +6 more
core +1 more source